HealthDay – FRIDAY, Feb. 19 (HealthDay News) — Rituxan (rituximab) has been
approved by the U.S. Food and Drug Administration to treat a slowly
progressing form of blood and bone marrow cancer known as chronic
lymphocytic leukemia (CLL), the agency said in a press release.
HealthDay – FRIDAY, Feb. 19 (HealthDay News) — Breast cancer rates are
declining, especially among women over 50 who have estrogen
receptor-positive tumors, and now a new study narrows down the reason
why.
HealthDay – FRIDAY, Feb. 19 (HealthDay News) — Surgery alone offers a
reasonable overall level of survival for patients with stage 1 small cell
lung cancer, a new study suggests.
HealthDay – FRIDAY, Feb. 19 (HealthDay News) — Slaving over a hot stove —
make that a hot gas stove — might raise your risk for certain
types of cancer.
AFP – US experts called Friday for toxicity tests on chemicals they suspect play a role in the development of breast cancer, a leading cause of death in American women.
AFP – US experts called Friday for toxicity tests on chemicals they suspect play a role in the development of breast cancer, a leading cause of death in American women.
HealthDay – Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
HealthDay – THURSDAY, Feb. 18 (HealthDay News) — The U.S. Food and Drug
Administration is defending its decision in late January to approve a new
diabetes drug, Victoza (liraglutide), even though animal studies suggest
it might increase the risk for a rare thyroid cancer.
HealthDay – THURSDAY, Feb. 18 (HealthDay News) — Researchers have found a
way to analyze the “fingerprint” of a cancer, and then use that
fingerprint to track the trajectory of that particular tumor in that
particular person.
AFP – US researchers unveiled a new way to fight cancer Thursday that uses the unique changes that occur in the DNA of cancerous cells to detect even the tiniest of cancers.
